Abstract A new N,N'-disubstitute benzimidazolium ligand and its Ag(I)-NHC complex have been synthesized", along with its symmetric N,N'-disubstitute benzimidazolium derivative of N-Heterocyclic carbene ligands. It was possible to make alkyl bromides or both by N-alkylating 5,6-methyl-1H-benzo[d]imidazole with fluor or non-fluor benzyl alkyl halides. In situ deprotonation of compounds with Ag₂O and a catalyzed reaction with KPF₆ were used to speed up the synthesis of the Ag(I)-NHC complex. The structural properties of all molecules were elucidated by NMR spectroscopy, PXRD, FTIR, elemental and ICP analysis. The structure of Ag(I)-NHC complexes was identified by analyzing powder PXRD diffraction pattern. According to the analysis, a PF₆⁻ anion and two NHC ligands are coordinated with an Ag⁺ ion in a linear geometry in each fluorinated benzyl complex. The antimicrobial activities of the compounds against Gram-positive, Gram-negative bacteria and fungi showed that the minimum inhibitory concentration value is 0.25 µg/mL. Ag + ions bound to ionic ligands increased the antimicrobial effects of these compounds.
No takes yet. Share an insight, caveat, or question.
Turkyılmaz et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: